Evidence map›Paper›PMID 42113352›Full record

ReviewBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026

Commercial and on-farm microbial bioinputs production systems: challenges, opportunities and current Brazilian regulatory framework.

Vanessa Lucas Xavier, Helson Mario Martins do Vale, João Ricardo Moreira de Almeida

Abstract readReview
In one paragraph

Review in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vanessa Lucas XavierGraduate Program of Microbial Biology, Institute of Biology, University of Brasília, Brasília, Brazil.ORCID http://orcid.org/0009-0007-7200-5328
Helson Mario Martins do ValeDepartment of Phytopathology. Institute of Biology, University of Brasília, Brasília, Brazil.ORCID http://orcid.org/0000-0002-5452-3873
João Ricardo Moreira de AlmeidaGraduate Program of Microbial Biology, Institute of Biology, University of Brasília, Brasília, Brazil. joao.almeida@embrapa.br.ORCID http://orcid.org/0000-0002-2902-5805

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial bioinputs have emerged as an innovative solution to more sustainable agriculture, with microorganisms playing diverse roles in plants. The increasing adoption of bioinput requires efficient production systems, which can be industrial facilities or on-farm biofactories - self-use units installed on rural properties. Thus, evaluating the opportunities and potential risks associated with bioinput production, particularly those based on bacterial and fungal strains, is crucial. This work presents a review of the on-farm production of bioinputs in Brazil. First, the Brazilian regulatory framework for bioinputs and the environmental and economic advantages of using bioinputs are summarized. Then, opportunities and challenges of bioproduct on-farm production are reviewed and discussed. The results highlight that producer and environmental safety, as well as risks to public health due to microbiological contamination in biofactories, appear as the main challenges in on-farm production. Indeed, the propagation of non-target microorganisms, which can be potentially pathogenic to humans, such as Escherichia coli and Salmonella sp., has been reported in various studies. In addition, the success of bioinputs produced on-farm depends on the ability of the biofactories to properly propagate the target microorganisms and guarantee the quality of them. For this, certain parameters, such as viability, cell counting, identity, and other characteristics, must be analyzed during the manufacturing process. In conclusion, the growth trend of bioinput adoption and the risks associated with this type of product require adequate management, including the adoption of quality control in the production process that considers biological safety parameters.

Indexed as

AgricultureBacteriaBiological ProductsFungiIndustrial MicrobiologyBrazilFarmsBiological ProductsBacterial bioinputsBiofactoriesBiological securityFood securityFungal bioinputsLegislation

Identifiers

PMID42113352
PMCPMC13161447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.